HOME >> MEDICINE >> NEWS
Spinifex secures $3.25m investment to develop pain therapy

A pain drug development company spun out of The University of Queensland has received a $3.25 million investment commitment to develop its innovative new pain therapy.

Spinifex Pharmaceuticals, an emerging biotechnology company specialising in the development of therapeutics for the treatment of neuropathic pain, has attracted investment from a syndicate including Symbiosis Group Limited, Melbourne-based GBS Venture Partners Limited and Uniseed.

Spinifex Pharmaceutical Managing Director, Dr Michael Thurn said he was delighted by the investment commitment which will help to accelerate their drug development program.

"We've several promising small molecules currently under evaluation and we plan to be in a position to start a formal toxicology program on one of those molecules in 2006," said Dr Thurn.

"The two main causes of neuropathic pain are through diabetes, affecting an estimated 45 per cent of diabetics, and through complications arising from infection with herpes zoster [shingles], known as post-herpetic neuralgia.

"We see a significant world-wide market for our pain therapy, and this investment will progress our efforts in delivering a novel solution."

Spinifex's core technology relates to the discovery (made by University of Queensland researchers led by Professor Maree Smith) of a novel pathway for the treatment of neuropathic pain. Professor Smith's group successfully validated this pathway using small molecules in well-defined animal models of neuropathic pain.

Managing Director of investment company Symbiosis, Dr Mark Harvey, said Spinifex was an attractive investment, led by a strong team with extensive experience in the international and local biotechnology industry

He said the neuropathic pain market targeted by Spinifex's technology was currently valued at US$3 billion.

"With a solid intellectual property position and several 'drug-like' molecules already in hand we expe
'"/>

Contact: Dr Michael Thurn
61-7-3842-3153
Research Australia
26-Jul-2005


Page: 1 2

Related medicine news :

1. University of Rochester spin-off secures $2 million in funding
2. Medical College of Wisconsin secures key contract from US HRSA
3. Molecular Profiling Institute secures $7.5 million in Series B funding
4. Menzies secures $1.8m in funding for the NT
5. ASU secures $3.9 million to study spinal cord injuries and neurological disorders
6. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
7. New PBS investment as PBS slows
8. Industry welcomes massive Victorian investment in medical research
9. European Science Foundation warns nanomedicine benefits will be lost without major investment
10. Medicares investment in quality improvement may not be paying off
11. Baby DVDs, videos may hinder, not help, infants language development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... ... ... AI for preventable harm analytics leader Jvion today announced that Jvion was ... Potential of AI”, which provides a “tip of the spear” analysis of the healthcare ... clients to complete a full KLAS analysis, Jvion was featured as having “by far ...
(Date:11/12/2019)... ... 12, 2019 , ... Raintree Rehab, a division of Raintree ... rehabilitation operators throughout the United States and Physitrack, an Apple Mobility Partner and ... a joint venture to develop and market clinical outcomes data solutions. , Both ...
(Date:11/11/2019)... Calif. (PRWEB) , ... November 11, 2019 , ... ... of business support services to dental groups in the United States, today announced ... the community of Lodi, CA. , Patients will enjoy convenient hours, comfortable offices ...
(Date:11/11/2019)... YORK (PRWEB) , ... November 11, 2019 , ... ... (CMP), today called for improved foodborne illness prevention and urges increased adoption of ... for a series of vegetable products sold to select retailers in the ...
(Date:11/9/2019)... ... 08, 2019 , ... Pennsylvania College of Health Sciences, the ... after the fourth quarter of the 2018-2019 academic year, the school’s NCLEX scores ... The College’s annual pass rate for the 2018-2019 academic year was 95.02%, maintaining ...
Breaking Medicine News(10 mins):
(Date:11/11/2019)... ... November 11, 2019 , ... Oak Street Health , ... has opened two new centers in Greensboro and Charlotte, with an additional center in ... offers an entirely different model of care that emphasizes quality of care rather than ...
(Date:11/11/2019)... ... 11, 2019 , ... The Naderi Center in Chevy Chase, Maryland, and Herndon, ... of sale, website for providing the highest level of care in the D.C Metro ... uses advanced financial technology in their daily business transactions using the Bank of America ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... class and have a major impact in the oncology field. While these ... to be overcome. Among these, defining valuable and adapted combination protocols, predicting ...
Breaking Medicine Technology:
Cached News: